Mauri, Gianluca
Vitiello, Pietro Paolo
Sogari, Alberto http://orcid.org/0000-0003-0612-6109
Crisafulli, Giovanni http://orcid.org/0000-0002-5511-1555
Sartore-Bianchi, Andrea http://orcid.org/0000-0003-0780-0409
Marsoni, Silvia http://orcid.org/0000-0002-5361-7122
Siena, Salvatore http://orcid.org/0000-0002-2681-2846
Bardelli, Alberto http://orcid.org/0000-0003-1647-5070
Article History
Received: 7 October 2021
Revised: 2 February 2022
Accepted: 17 February 2022
First Online: 9 March 2022
Competing interests
: SS is advisory board member for Amgen, Bayer, BMS, CheckmAb, Daiichi-Sankyo, Guardant Health, Merck, Novartis, Roche-Genentech, and Seattle Genetics. AS-B is advisory board member for Amgen, Bayer, Sanofi and Servier. AB is a member of the scientific advisory board of NeoPhore, Illumina and Inivata, and a shareholder of NeoPhore. PPV has acted as a consultant of Biocartis and speaker for Merck. The remaining authors declare no competing interests.
: Not applicable.
: Not applicable.